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OBJECTIVE: To assess the prevalence of obesity and central obesity in an urban Palestinian population and their associations with
selected co-morbidities, including diabetes, hypertension and dyslipidaemia.
DESIGN: A population-based cross-sectional survey in an urban Palestinian community.
SUBJECTS: Men and women aged 30 – 65 y residing in the urban community, excluding pregnant women.
MEASUREMENTS: According to WHO guidelines, obesity for men and women was defined as BMI30 kg m72, while pre-
obesity was defined as BMI 25 – 29.9 kg m72. Central obesity was defined as a waist-to-hip ratio (WHR) of >0.90 in men and
>0.85 in women.
RESULTS: The prevalence of obesity in this population was high at 41% (49% and 30% in women and men, respectively).
Central obesity was more prevalent among men (59% compared to 25% in women). After adjusting for the effects of age, sex,
smoking and each other, obesity and central obesity were found to be significantly associated with diabetes, low HDL-
cholesterol and elevated triglycerides in separate logistic regression analyses. Central obesity was also significantly associated
with hypertension (OR 2.26, 95% CI 1.30 – 3.91).
CONCLUSION: Obesity and central obesity are prevalent in the urban Palestinian population. Their associations with diabetes,
hypertension, and dyslipidaemia point to a potential rise in cardiovascular disease (CVD). An understanding of the reasons
behind the high prevalence of obesity is essential for its prevention as well as for the prevention of the morbidities to which it
may lead.
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Introduction
In addition to its association with a variety of morbidities,
such as gallbladder disease, osteoarthritis, and certain types
of cancer, obesity also has a well-established association with
cardiovascular disease (CVD) and its risk factors.1,2 A number
of metabolic abnormalities that lead to CVD are associated
with obesity, including dyslipidaemia, raised blood pressure,
insulin resistance and glucose intolerance, and abnormalities
in the coagulation system.3 This collection of factors is
known as the metabolic syndrome.4 Central obesity has
also been found to be an independent contributor to CVD at
a given level of obesity and is included in the WHO working
definition of the metabolic syndrome.4,5
The exact mechanisms whereby obesity predisposes to
this collection of risk factors are not yet fully understood.
What is known, however, is that the prevalence of obesity
has been increasing worldwide due, in large part, to rising
urbanization, increased availability of food, and decrease in
physical activity.3
In the Eastern Mediterranean Region (EMR), economic
development has precipitated profound social and demo-
graphic changes over the past two decades.6 Food availability
and consumption have increased rapidly in many countries,
and lifestyles have become more sedentary, as growing
urbanization lessens the need for physical labour.7,8 Surveys
from the region indicate alarmingly high prevalences of
obesity, especially in urban areas and among women.9 – 13
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In the Palestinian West Bank, a recent survey conducted in a
rural community found the prevalence of obesity to be
42.1% in women and 19.5% in men when age-standardized
to the WHO ‘world’ standard population.14 In view of the
fact that 46.5% of the Palestinian West Bank population now
lives in urban areas, it is important to obtain data on the
prevalence of obesity and its co-morbidities there.15 The
objectives of the present study are to determine the preva-
lence of obesity in an urban Palestinian community and to
assess its associations with selected co-morbidities, including
diabetes, hypertension and dyslipidaemia.
Methods
The population surveyed in this study resides in a well-
defined, predominantly Muslim, urban community in the
heart of Ramallah, which is a major city located in the centre
of the West Bank, 16 km north of Jerusalem.
A household census was first conducted to identify eligi-
ble subjects. Eligibility was based on age (30 – 65 y), residence
within the survey area for at least 6 months prior to the
beginning of the study, physical ability to participate, and
mental ability to comprehend and consent to survey
procedures.
Characteristics of the study population are summarized in
Table 1. Based on the inclusion criteria, and after exclusion
of seven pregnant women, a total of 485 individuals (295
women and 190 men) participated in the study, representing
an overall response rate of 59.2% (71% in women and 47%
in men).
The model protocol by Dowse and Zimmet was
followed.16 Survey procedures included anthropometric
measurements (height, weight, and waist and hip circumfer-
ences), fasting capillary blood glucose (FBS) measurement,
an oral glucose tolerance test (OGTT), blood pressure mea-
surement, blood lipids tests, and completing a questionnaire
on socio-demographic and smoking information. The study
population and methods have been described in more detail
in a previous report.17
According to WHO guidelines, obesity for men and
women was defined as BMI30 kg m72, while pre-obesity
was defined as BMI 25 – 29.9 kg m72.18 Central obesity was
defined as a waist-to-hip ratio (WHR) > 0.90 for men and
>0.85 for women.4 Diabetes was determined by the results
of the OGTT using venous plasma or by reporting a physi-
cian’s diagnosis prior to the survey. The diagnostic values for
the OGTT, according to WHO guidelines of 1985, were
>11.1 mmol=l at 2 h after glucose load.19 Persons with pre-
viously diagnosed diabetes who were on oral hypoglycemic
agents or insulin injections were excluded from the OGTT.16
Hypertension was defined as blood pressure 140=90 mmHg
or a physician’s diagnosis of hypertension prior to the survey.
Venous serum samples were used to determine levels of
blood lipids. The cut-off for determining raised triglycerides
was 1.70 mmol=l, and low HDL-cholesterol was defined as
<0.90 mmol=l in men and < 1.0 mmol=l in women.4
Data analysis
Statistical analysis was conducted using the Statistical Pack-
age for the Social Sciences for Windows (SPSSWIN), version
8.0. The prevalence of obesity was presented both as a raw
percentage and adjusted for confounding by age and sex.
Adjustment was made to the age and sex structures of the
Palestinian population15 as well as to the age structure of the
WHO ‘world’ population by direct standardization.20 The
associations of BMI and WHR with age-group were assessed
by analysis of variance (ANOVA), and the w2 test was used to
test the difference between prevalence values (Tables 2 and
3). Descriptive bivariate analysis between the metabolic
factors as continuous variables and levels of BMI (normal,
pre-obese and obese) was performed using multiple regres-
sion analysis, including age as a categorical variable (Table 4).
In logistic regression analyses controlling for potential con-
founding by age, sex and smoking, associations were assessed
between (a) obesity and (b) central obesity as categorical
independent variables and, taken one by one, diabetes,
hypertension and dyslipidaemia as dependent variables
(Table 5). Potentially significant interactions between inde-
pendent variables were examined by inclusion of their pro-
duct terms in each model. In the model with diabetes as the
dependent variable, the interaction between age and obesity
was significant, so age-specific odds ratios are presented. The
P-value 0.05 was used as a cut-off level for significance.
Table 1 Characteristics of the study population
Males Females
n 190 295
Age (y) (s.d.)a 42.7 (9.6) 45.3 (10.5)
Years of education (s.d.)b 8.9 (4.8) 7.1 (5.1)
Currently smoking (%)c 58.7 18.1
aP (independent-samples) t-test)¼ 0.006.
bP (independent-samples t-test)<0.001.
cP (w2 test)< 0.001.
Table 2 Mean BMI and the prevalence of pre-obesity (BMI 25 – 29.9)
and obesity (BMI30) by sex and age
BMI Pre-obese Obese
Age group n Mean (s.e.) BMI 25 – 29.9 % (n) BMI30 % (n)
Male
30 – 34 44 25.6 (0.52) 45.5 (20) 11.4 (5)
35 – 44 80 27.4 (0.47) 45.0 (36) 28.8 (23)
45 – 54 39 28.3 (0.68) 33.3 (13) 43.6 (17)
55 – 65 27 28.8 (1.08) 29.6 (8) 44.4 (12)
30 – 65 190 27.4 (0.32) 40.5 (77) 30.0 (57)
Female
30 – 34 61 28.0 (0.83) 42.6 (26) 27.9 (17)
35 – 44 83 29.5 (0.58) 30.1 (25) 48.2 (40)
45 – 54 78 31.3 (0.68) 37.2 (29) 53.8 (42)
55 – 65 73 31.9 (0.74) 26.0 (19) 61.6 (45)
30 – 65 295 30.2 (0.36) 33.6 (99) 48.8 (144)
Obesity in an urban Palestinian population
HF Abdul-Rahim et al
1737
International Journal of Obesity
Results
The mean BMI and the prevalence of pre-obesity and obesity
by age and sex are presented in Table 2. The age-specific and
overall BMI averages were significantly higher in females
than in males. The difference in the prevalence of obesity,
but not pre-obesity, was significant between the sexes
(P<0.001 and P¼0.12, respectively). The crude prevalence
of obesity for both sexes was 41.4% (95% CI 37.0 – 45.8). The
point prevalence rose to 43.3% (95% CI 38.9 – 47.7) when
adjusted to the age structure of the WHO ‘world’ population
and dropped to 38.1% (95% CI 33.8 – 42.4) when adjusted to
age and sex structures of the Palestinian population. In total,
70.5% of men and 82.4% of women had a BMI25. There
was a significant positive association between BMI and age in
both sexes (P¼0.007 in males and P< 0.001 in females).
Similarly, the prevalence of obesity increased steadily with
age in both sexes, reaching a high of 61.6% in the 55 – 65
age-group of women. The mean WHR was significantly
higher among males than females (P<0.001), and the pre-
valence of central obesity among males (58.9%) was more
than double that in females (Table 3).
Table 3 Mean waist-to-hip ratio (WHR) and the prevalence of abdominal obesity (WHR>0.90 in men and >0.85
in women) by sex and age
Males Females
Age group n WHR mean (s.e.) WHR 0.90 %(n) n WHR mean (s.e.) WHR 0.85 %(n)
30 – 34 44 0.88 (0.0082) 40.9 (18) 61 0.77 (0.0067) 3.3 (2)
35 – 44 80 0.91 (0.0068) 56.3 (45) 83 0.80 (0.0065) 13.3 (11)
45 – 54 39 0.94 (0.011) 76.9 (30) 78 0.82 (0.0062) 30.8 (24)
55 – 65 27 0.95 (0.015) 70.4 (19) 73 0.86 (0.0077) 52.1 (38)
30 – 65 190 0.92 (0.0049) 58.9 (112) 295 0.81 (0.0038) 25.4 (75)
Table 4 Mean risk factor values and their standard errors (s.e.) in normal-weight (BMI<25), pre-obese (BMI 25 –
29.9) and obese (BMI30) males and females
BMI
Metabolic factor Normal Pre-obese Obese P-value
a
Males Systolic BP (mmHg) 115.4 (1.86) 124.3 (2.09) 132.1 (2.28) <0.001
WHR 0.85 (0.0058) 0.92 (0.0058) 0.97 (0.007) <0.001
FBS (mmol=l) 4.11 (0.20) 4.22 (0.13) 4.86 (0.36) 0.124
2 h-glucose (mmol=l)b 4.67 (0.16) 4.84 (0.19) 5.42 (0.26) 0.048
Cholesterol (mmol=l) 4.49 (0.12) 5.10 (0.13) 5.56 (0.25) <0.001
HDL-chol (mmol=l) 0.89 (0.038) 0.74 (0.030) 0.77 (0.035) 0.002
LDL-chol (mmol=l) 3.15 (0.12) 3.77 (0.13) 3.99 (0.16) <0.001
TG (mmol=l) 1.21 (0.10) 1.85 (0.20) 3.0 (0.56) 0.001
Females Systolic BP (mmHg) 111.4 (2.52) 118.5 (2.06) 125.9 (1.67) 0.003
WHR 0.76 (0.0067) 0.80 (0.0064) 0.84 (0.0049) <0.001
FBS (mmol=l)
b
4.75 (0.27) 4.70 (0.15) 5.64 (0.22) 0.052
2 h-glucose (mmol=l)
b
5.08 (0.19) 5.73 (0.24) 6.37 (0.22) 0.006
Cholesterol (mmol=l) 4.88 (0.16) 5.17 (0.12) 5.32 (0.12) 0.580
HDL-chol (mmol=l) 1.15 (0.049) 0.95 (0.027) 0.90 (0.024) <0.001
LDL-chol (mmol=l) 3.32 (0.16) 3.71 (0.12) 3.80 (0.084) 0.392
TG (mmol=l) 0.95 (0.074) 1.41 (0.087) 2.07 (0.23) 0.002
aP-value obtained from multivariate regression analysis of each metabolic factor on the three levels of obesity and age (30 –
34, 35 – 44, 45 – 54, 55 – 65).
bFBS values include all subjects regardless of their diabetes status, while 2 h-glucose levels exclude persons with previously
diagnosed diabetes.
Table 5 Age-, sex- and smoking-adjusted odds ratios of hypertension,
diabetes and dyslipdaemia for overall obesity (BMI30) and central
obesity (WHR0.85 in females and WHR0.90 in males)
Overall obesity Central obesity
OR (95% CI)a P-value OR (95% CI)a P-value
Hypertension 1.53 (0.92, 2.54) 0.10 2.26 (1.30, 3.91) 0.0036
Diabetes
b
2.11 (1.07, 4.18) 0.031
Age 30 – 44 1.60 (0.44 – 5.82) 0.48
Age 45 – 54 12.68 (2.78 – 57.84) 0.001
Age 55 – 65 0.88 (0.35 – 2.24) 0.79
Low HDL-chol 2.22 (1.42, 3.47) 0.0005 2.14 (1.31, 3.49) 0.0022
Hypertrigly-
ceridaemia
2.04 (1.30, 3.18) 0.0018 4.13 (2.55, 6.68) <0.001
aAge groups used in the logistic regression model (30 – 44, 45 – 54, 55 – 65).
bOdds ratios for the interaction of obesity with age. The odds ratio for each
age group reflects the effect of obesity within that group.
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The bivariate associations between various metabolic fac-
tors and levels of BMI are presented in Table 4. A significant
positive association was seen in both sexes between BMI
levels and systolic blood pressure, WHR, 2 h-glucose, and
triglycerides, after adjusting for age, and a significant nega-
tive association with HDL-cholesterol was also seen in both
sexes. The association of FBS with BMI levels did not reach
the level of significance in either sex, while total and LDL-
cholesterol were significantly associated with BMI only in
men. The association was not confounded by central obesity,
as it was tested in a regression analysis after stratification
into tertiles of WHR.
When age, sex and smoking were adjusted for in logistic
regression analyses for each metabolic factor, obesity and
central obesity were significantly associated with low HDL-
cholesterol and hypertriglyceridaemia, in the presence of
each other in the model (Table 5). Both types of obesity
were also associated with diabetes, but there was a significant
interaction between obesity and age, such that obesity was
only significantly associated with diabetes in the 45 – 54 age
group. The odds ratios presented in Table 5 reflect the
association of obesity with diabetes within each age group.
Central obesity, but not obesity, was also significantly asso-
ciated with hypertension.
Discussion
Population-based data on the anthropometric measurements
of Palestinian adults have been lacking until recently. A
community-based rural survey found the age-adjusted pre-
valence of obesity to be 42.1 and 19.5% among women and
men, respectively.14 The study concluded that the prevalence
of obesity was high for a rural population and that it pointed
to an emerging trend of CVD morbidity and mortality. The
present study provides for the first time community-based
data on obesity in an adult urban Palestinian population,
which show, as expected, that the prevalence of obesity there
is even higher.
A high response rate is important for minimizing selec-
tion bias. In this survey, intensive efforts were made to
encourage participation, including recruitment of local
field workers and securing the approval and support of
local community leaders. Approximately 62% of families
with eligible individuals participated in the survey. Response
among men was problematic however (47%), in part due to
the time demand of the survey protocol (approximately 2 h),
which conflicted with work schedules. Among women, the
response was higher (71%), since most were not employed in
the formal sector. Another reason cited for non-response was
the availability of a number of health facilities in this urban
centre, thus reducing the interest in obtaining a health
assessment through the survey. Though probably of varying
quality, health services are accessible to all income levels,
because of the mix of private and government providers and
insurance types. Thus it may be reasonable to assume that
the study participants were not only persons of lower income
who were unable to access health services.
An examination of the demographic characteristics of
non-responders is essential, in order to anticipate the direc-
tion of the potential bias associated with low response. The
age, sex, education and SES levels of responders and non-
responders were compared, and no significant differences
were found. The findings of this study can thus be general-
ized to urban communities similar to the survey site in the
center of the West Bank, especially in middle-to-lower
income communities.
Because of the excess of females and due to the fact that
the study population was slightly older than the Palestinian
population, sex and age adjustments were applied, resulting
in a drop of the point prevalence of obesity from 41.4 to
38.1%. The prevalence of obesity among women in this
study was high, where approximately 50% of women and
30.0% of men had a BMI30. Since health risks associated
with increasing BMI are graded and begin at a BMI< 25,18
the high prevalence of BMI25 in this population is espe-
cially alarming. Although direct comparisons are difficult
because of differences in the study populations’ age groups,
these findings seem to fall within the range of obesity
prevalences found by other studies in the EMR, including
Kuwait, Saudi Arabia and Jordan.10,11,13
Both obesity and fat distribution are known to be asso-
ciated with CVD and its risk factors.1,21 Because of its cross-
sectional design, this study is not able to show causality, as
exposure and effect are measured simultaneously. It is possi-
ble that subjects who had been diagnosed with diabetes or
hypertension prior to the survey had changed their lifestyles,
including their body weight, in response to their condition.
However, the significant associations of obesity and central
obesity with diabetes, low HDL-cholesterol and elevated
triglycerides after controlling for age, sex and smoking, are
consistent with the findings of prospective studies.22 The
effect of age on the association between BMI and morbidity
has been debated.23 In an analysis of cross-sectional data
from the Third National Health and Nutrition Examination
Survey (NHANES III) in the United States, it was observed
that the relationship of obesity with the comorbidities stu-
died (including diabetes) was generally strongest among the
younger age groups.23 The interaction of obesity with age
found in this study in relation to diabetes requires further
investigation.
Conclusion
The prevalence of obesity and central obesity in urban
Palestinian men and women is high, and it is associated
with dyslipidaemia, hypertension and diabetes. Chronic dis-
eases pose a considerable burden of morbidity and premature
mortality, and their financial toll can be daunting, especially
for health systems with limited resources, making pre-
vention the strategy of choice. In the Palestinian setting,
future research should focus on elucidating the causes of
Obesity in an urban Palestinian population
HF Abdul-Rahim et al
1739
International Journal of Obesity
overweight and obesity, including changing nutritional
habits, physical activity patterns and cultural attitudes, as a
first step towards prevention.
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